↓ Skip to main content

Dove Medical Press

Article Metrics

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
83 Mendeley
Title
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
Published in
Therapeutics and Clinical Risk Management, June 2012
DOI 10.2147/tcrm.s24239
Pubmed ID
Authors

Athanasios Anastasilakis

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Gambia 1 1%
Unknown 81 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 19%
Student > Master 14 17%
Researcher 10 12%
Student > Bachelor 10 12%
Other 9 11%
Other 15 18%
Unknown 9 11%
Readers by discipline Count As %
Medicine and Dentistry 43 52%
Biochemistry, Genetics and Molecular Biology 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Chemistry 4 5%
Nursing and Health Professions 3 4%
Other 9 11%
Unknown 14 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2016.
All research outputs
#11,281,280
of 19,163,209 outputs
Outputs from Therapeutics and Clinical Risk Management
#561
of 1,161 outputs
Outputs of similar age
#129,611
of 275,850 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#21
of 51 outputs
Altmetric has tracked 19,163,209 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,161 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,850 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.